Haematology 2018

Duration of response with ibrutinib

Overall survival rate with ibrutinib

At the time of analysis (primary analysis of progression-free survival), the median overall survival had not been reached as 70 patients (63%) were still alive. 1

• 17.5 months estimated median response duration • 13.9 months estimated median progression-free survival

• Estimated 58% overall survival at 18 months 1

1. Wang M et al. N Engl J Med 2013; 369: 507-516.